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Abstract. We have characterized the adhesion mole- 
cule HEMCAM, which is expressed by hemopoietic 
progenitors of embryonic bone marrow. HEMCAM 
belongs to the immunoglobulin superfamily and con- 
sists of the V-V-C2-C2-C2 Ig domains. There are three 
mRNA splice variants. One has a short cytoplasmic tail; 
another has a long tail; while the third seems to lack 
transmembrane and cytoplasmic regions. Except for 
the NH2-terminal sequence, HEMCAM is identical to 
gicerin, a molecule involved in neurite outgrowth and 
Wilm's kidney tumor progression in the chicken and it 
is significantly homologous with MUC18 a molecule in- 
volved in melanoma progression and metastasis in hu- 
man beings. 
In the bone marrow the HEMCAM  ÷ cell population 
contains c-kit + subsets. HEMCAM  ÷ cells coexpressing 
the receptor tyrosine kinase c-kit give rise to T cells at a 
frequency of 0.17 when injected intrathymically in con- 
genic animals. As HEMCAM  ÷, c-kit + cells differenti- 
ate into myeloid and erythroid CFU's the double-posi- 
tive cell population seems to contain precursors for 
multiple lineages. HEMCAM promotes cell-cell adhe- 
sion of transfected cells. Cross-linking of murine HEM- 
CAM leads to cell spreading of T-lymphocyte progeni- 
tors adhering to the vascular adhesion molecules, 
PECAM-1 and VCAM-1. Thus, HEMCAM is likely to 
be involved in cellular adhesion and homing processes. 
large  proportion  of immunoglobulin  supeffamily 
(IgSF)  1 molecules serve as adhesion receptors on 
the cell surface. In the recent literature there has 
emerged a prominent subgroup with a characteristic V-V- 
C2-C2-C2 Ig domain structure.  Important  representative 
members of this subgroup of molecules are B-CAM (hu- 
man), Lutheran blood group antigen (human), BEN/DM- 
GRASP/SC1  (chicken),  ALCAM  (human),  KG-CAM 
(rat), irreC-rst  (drosophila), Neurolin (goldfish), Gicerin 
(chicken), and MUC18 (human) (3-5, 26, 28, 38, 41, 45, 47, 
57, 60). Although most of these molecules are involved in 
adhesion and migration processes of neural cells, several 
of them are also found directly or indirectly  associated with 
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ceils  of the immune  system, with epithelial  cells,  and/or 
with vascular endothelium. 
BEN is expressed by embryonic hemopoietic progenitor 
ceils from the bone marrow and immature thymocytes, but 
it is absent from most mature leukocytes (8). BEN-posi- 
tive bone marrow cells develop macrophage, granulocyte, 
thrombocyte, and  erythrocyte colonies when allowed to 
differentiate in vitro in the presence of appropriate  fac- 
tors. Mature resting peripheral  T-lymphocytes are virtu- 
ally negative  for BEN  expression,  however this  can  be 
overcome by mitogenic or allogeneic stimulation of these 
cells; thus BEN is a T cell activation marker (7). ALCAM 
(activated leukocyte-cell adhesion molecule), the human 
homologue of BEN, has recently also been identified as an 
adhesion ligand for CD6 (3) that functions as an accessory 
protein in T  cell activation;  antibodies against  CD6 can 
prevent transplant  rejection of kidney and bone marrow 
(2, 25, 48). 
Gicerin is transiently expressed in the developing ner- 
vous system and kidney (57, 58). Cloning and transfection 
experiments have demonstrated that the adhesive interac- 
tions mediated by gicerin include homophilic (gicerin-gic- 
erin) or heterophilic contacts between gicerin and neurite 
outgrowth  factor  (NOF),  a  700-kD  extracellular  matrix 
glycoprotein of the laminin  family (18). Antibodies against 
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chains but not with the 330-kD putative A  chain of NOF 
(61, 63). Immunohistochemical analysis suggests that both 
homophilic and heterophilic gicerin adhesion may be of 
importance during ontogeny of the kidney (58). After kid- 
ney development has been completed, gicerin expression 
is suppressed in most cell types in kidney. As neoplastic re- 
nal tissue re-expresses gicerin, it is a potential indicator for 
tumor tissue (58). Such de novo expression by tumors has 
also been found for MUC18, another V-V-C2-C2-C2 mol- 
ecule (28). MUC18 expression is gradually increased dur- 
ing tumor progression of human melanomas, and its adhe- 
sive property might be involved in tumor cell migration 
and metastasis. 
To initiate T cell differentiation, hemopoietic stem cells 
must migrate to the thymus (37, 39). Several studies have 
shown that hemopoietic progenitors are  transported via 
the blood to the vicinity of the thymus when adhesion mol- 
ecules result in the attachment to the thymic endothelium. 
Both a6 integrin and CD44 expressed on vascular endo- 
thelium are involved in this process (10, 51). Extravasation 
and  migration of progenitors  in  the  perivascular  space 
through the perithymic mesenchyme towards the thymic 
epithelium requires  interaction with extracellular matrix 
molecules (52).  Another adhesion step between the pro- 
genitor T cell and the thymic epithelium is thought to oc- 
cur before the progenitor cell enters the thymus. Identi- 
fication  of  the  adhesion  molecules  involved  in  thymic 
homing requires the isolation of hemopoietic progenitor 
cells from the tissue in which they are most abundant. 
Attempts to characterize hemopoietic stem ceils have 
been  made with mouse and human tissue.  In the  adult 
mouse, bone marrow stem cells, which can reconstitute all 
hemopoietic cell lineages, are  of the phenotype Thy-1  l° 
Sca-1 + and lineage marker negative (lin-) (20). A  similar 
stem cell population was isolated from human bone mar- 
row although the type of marker molecules was different 
(CD34 ÷, lin-) (20).  In both cases, the proportion of stem 
cells to total leukocytes is very low (<0.05 %)(20) although 
it is significantly increased in embryonic tissue. The bone 
marrow and the blood of human embryos contains CD34  ÷ 
cells that give rise to lymphocytes in SCID mice with hu- 
man thymus transplants (40).  From mouse blood at em- 
bryonic day 15.5 (E15.5), it was recently possible to sepa- 
rate pro-thymocytes (Thy-1 +, c-kit  l° and CD3- cells) from 
pluripotent hemopoietic progenitors (Thy-l-, c-kit  +) (49). 
With birds, unlike mammals, one can obtain experimental 
access  to  precisely  staged  embryos.  Hemopoietic  stem 
cells emerge in chicken bone marrow as early as El0, and 
the percentage of pro-T cells that can migrate to the thy- 
mus peaks at E13 (11). In the present work, we measured 
the T cell differentiation potential of hemopoietic progeni- 
tors by intrathymic injection into congenic animals. Using 
this method, we show that an El3 embryonic bone marrow 
population expressing c-kit and the antigen recognized by 
a monoclonal antibody (mAb) c264 gives rise to T cells at 
frequencies of 0.17. The mAb c264 facilitated the cloning 
and sequencing of the antigen which we call hemopoietic 
cell adhesion molecule (HEMCAM). This adhesion protein 
of the V-V-C2-C2-C2  IgSF subgroup was highly homolo- 
gous  to  the  human  melanoma  progression  molecule 
MUC18 and gicerin. 
Materials and Methods 
Animals 
Embryonated eggs from H.B19 strain of White Leghorn chickens were 
produced at the Basel Institute Chicken Facility at Gipf-Oberfrick (Swit- 
zerland). Fertilized eggs were incubated at 38°C and 80% humidity in a 
ventilated incubator. The two congenic lines, H.B19ov  + and H.B19ov-, 
differ in the expression of the ov antigen on thymocytes and T cells. The 
ov antigen is recognized by mAb 11A9 (11, 12, 19). 
Monoclonal Antibodies 
A hybridoma producing mAb c264 (IgG2b) was obtained after fusion of 
Sp2/0 myeloma cells with lymph node cells from a BALB/c mouse immu- 
nized with a mixture of El5 and El6 thymocytes from H.B15, H.B19, and 
H.B21 chicken embryos as previously described (31). Anti-HEMCAM an- 
tibody c236 (IgG2a) which works better for histochemistry and immuno- 
precipitation than c264 was made against soluble HEMCAM protein. 
To  obtain a  chicken c-kit-specific mAb, a  mouse was immunized with 
Sp2/0 cells, Sp/chkit4A4,  transfected with chicken c-kit eDNA.  Other 
mAb have been described earlier: anti-Bu-la, a B cell marker (L22) (44), 
anti-CD4 (2-6)  (31), anti-CD8 (11-39)  (30), anti-ov (llA9) (19), anti-~ 
TCR (TCR1), anti-ul31  TCR (TCR2), anti-a132 TCR (TCR3), and anti- 
CD3 (CT3) were purchased from Southern Biotechnology (Birmingham, 
AL).  FITC  (5(6)-Carboxyfluorescein-N-hydroxysuccinimidester [FLUOS]; 
Boehringer  Mannheim,  Germany),  biotin  (Biotin-N-Hydroxysuccini- 
midester, NHS-D-Biotin; Calbiochem, La Jolla, C A) and phycoerythrin 
(R-Phycoerythrin, Molecular Probes, Leiden, The Netherlands) conjuga- 
tion of mAb were done in our laboratory according to the manufacturers' 
instructions. 
Histochemlstry 
Our indirect method uses peroxidase as the detection reagent. Frozen tis- 
sue sections (5 I~m) were fixed in acetone for 5 min at room temperature 
(RT), rehydrated with PBS containing 1% bovine serum albumin (PBS/ 
BSA), and loaded with antibody c236 (hybridoma supernatant). After 60 
min incubation at RT, the sections were washed twice with PBS/BSA and 
incubated for 30 min with goat anti-mouse IgG (H+L) antibody coupled 
to biotin (dilution 1:400; Southern Biotechnology). The biotin indirectly 
bound to the antigen was detected by a bridging technique using a com- 
mercial kit (ABC standard, PK 6100;  Vector Labs , Burlingame, CA). 
Briefly, avidin was allowed to bind to the biotinylated secondary antibody, 
and the remaining free-binding sites of ligated biotin were used by bioti- 
nylated peroxidase. This indirect labeling intensifies the signal without in- 
creasing background staining. Labeling was developed for 30 rain by 3, 3'- 
Diaminobenzidine (0.05% in 50 mM Tris buffer, pH 7.5; both from Sigma 
Chem. Co., St. Louis, MO) after addition of 0.005% 1-1202. The contrast of 
the immuno-staining was further intensified by exposing the section to a 
solution of 0.5%  CuSOd0.9%  NaCI  for 10 min. Tissues were counter- 
stained with Meyer's hemalum solution (Merck, Darmstadt, Germany). 
Sections were mounted in Mowiol and analyzed under a Zeiss Axiophot 
microscope equipped with a CCD video camera (Zeiss, Oberkochen, Ger- 
many) and a Sony videoprinter UP-5000P. 
Imraunoprecipitation 
Thymocytes (5  x  107, viability >95%) were surface-labeled with 1 mCi 
Na125I (Amersham, Buckinghamshire, UK) by the lactoperoxidase cata- 
lyzed method (22). The cells were lysed in 150 mM NaC1, 50 mM Tris-HCl 
(pH 7.4), 5 mM EDTA, 0.1% NAN,, 1 mM pefabloc (Boehringer Mann- 
heim), 1 i~g/ml leupeptin, 1 I~g/ml pepstatin A, 100 I~g/ml trypsin inhibitor, 
20 mM ~-amino-n-caproic-acid, 2 I~g/ml antipain, 20 mM iodoacetamide 
(all reagents from Sigma), and 1% NP-40 (Calbiochem) for 45 rain at 4°C. 
After centrifugation (10,000 g, 45 min at 4°C), the lysate was immunopre- 
cipitated by a solid phase method (SPIT) (59), and absorbed molecules 
were eluted with 1% SDS in 50 mM Tris-HCl with 5% 2-mercaptoethanol 
(2-ME). For glycolytic enzyme digestions, the immunopreciptates were 
eluted with 0.5% SDS, 0.1 M 2-ME for 20 min at 80"C. The reaction condi- 
tions were adjusted according to manufacturer's instructions and the im- 
munoprecipitates were incubated overnight at 37°C in the presence of 50 
U/ml N-giycanase (Genzyme, Boston, MA).  Undigested controls were 
treated similarly but without the addition of enzymes. Samples were pre- 
pared for electrophoresis by addition of 6×  sample buffer containing 
2-ME. Immunoprecipitates were electrophoresed on 7.5 % SDS PAGE. 
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For single, two-, or three-color analysis cells (106 ) were incubated with 
hybridoma supernatants or purified  mAb, washed, and incubated with 
FITC-conjugated anti-mouse Ig isotype specific antibodies (Southern Bio- 
technology). After washing, the cells were blocked with normal mouse 
serum and then stained with PE-conjugated mAb. For three-color analysis 
the cells were washed again and incubated with a biotin-conjugated mAb 
followed by streptavidin-Tricolor reagent (Caltag Labs, South San Fran- 
cisco,  CA).  A  FACScan was used for  immunofluorescence analysis, a 
FACStar Plus (Becton Dickinson, Mountain View, CA) was used for sorting. 
Intrathymic Injection  and Differentiation of  Embryonic 
Bone Marrow Cells 
To prepare bone marrow cells from congenic ov  + E13.5 donor animals, 
cells were flushed from the cavity of the isolated femurs and tibiae with a 
25G 5/8-inch long syringe containing medium (DMEM containing 10% 
FCS), washed twice in PBS, counted, and adjusted to the required cell 
concentration (11). The recipient, 14-day-old ov- congenic chicks were ir- 
radiated with 600 tad from a  137Cs source (110 rad/min) (Gamma Cell Ir- 
radiator, Atomic Energy of Canada, Ottawa, Canada) about 6 h before 
receiving the donor bone marrow cells. Before intrathymic injection, the 
recipients were  anesthetized with an i.m. injection of 0.4 ml ketamine 
(Imalgene 500, Rhone Merieux, France), diluted 1:10 in PBS followed by 
a short inhalation of halothane (HOECHST, Frankfurt, Germany). A mid- 
line incision was made in the skin on the dorsal side of the neck to expose 
the upper thymic lobes on each side. The donor bone marrow cells were 
injected into two upper lobes on each side. Each lobe was injected with 
10 ixl cell suspension in PBS (3-6 ×  105 cells/thymus lobe) in a  1-ml sy- 
tinge (Insulin syringe, Becton Dickinson, San Jose,  CA) placed into  a 
Ttidek Stepper  (Ttidek, Brookfield,  CT). The incision was closed with 
three wound clips (Autoclip, Clay Adams, Becton Dickinson Primary Care, 
Sparks, MD). After the operation, the chickens were kept under an infra- 
red lamp until they were fully conscious. The animals recovered rapidly 
and no special care was necessary for housing. 2-4 wk after chimera con- 
struction the chickens were sacrificed and cells from the injected thymus 
lobes  isolated.  Donor-derived  ceils were  identified  by  immunofluores- 
cence with the mAb llA9 (isotype IgM) directed against the ov+-antigen. 
cDNA Cloning and Sequencing 
mRNA from E13.5 H.B19ov  ÷ thymocytes was prepared by a  FastTrack 
mRNA isolation kit (Invitrogen, De Schelp, Netherlands). A  library of 
eDNA was constructed from 15 p,g of the mRNA in the COS cell expres- 
sion vector pCDA3 (Invitrogen). The library consisted of 2.2 ×  106 pri- 
mary clones, was amplified once, and had an average cDNA size of 1.0 kb. 
Transfection of adherent COS.7 cells with the library and screening of the 
transfected cells with mAb was done as described earlier  (64).  Briefly, 
COS.7 cells grown in a 75-cm  2 tissue culture flask (Falcon 3111;  Becton 
Dickinson, Franklin Lakes, N J) at ~80% confluence were trypsinized by 
incubation in PBS/0.02%  EDTA/0.25%  trypsin and 4  x  l0  s cells were 
transfected in 3 ml Hepes-buffered DMEM (HBD) containing 500 ~,g/ml 
DEAE-dextran, 100 p,M chloroquine (Sigma), and 3 ixg DNA for 2 h  at 
37°C. The cells were washed in HBD, cultured on tissue culture slides 
(Lab-Tek, Chamber Slide, Nunc, Naperville, IL) in DMEM/10% FCS for 
48 h, rinsed in PBS, fixed on culture slides with ice-cold acetone/methanol 
(1/1  vol) for 2  min, washed twice with PBS, and blocked with PBS/5% 
FCS for 30 min followed by 1 h  incubation with c264 mAb. The slides 
were washed three times with PBS/0.05 % Tween 20 (PBST) followed by a 
1-h incubation with peroxidase-conjugated goat anti-mouse Ig (DAKO, 
Glostrup, Denmark) diluted 1:200 in PBS/5% FSC. Enzyme activity was 
visualized with a 1:20 dilution of a 4-mg/ml stock of 9-amino-3-ethylcarba- 
zol in N,N-dimethylformamide in 0.1 m  NaAc (pH 4.8) containing 0.1% 
H202 for 30-60 min. Slides were washed and screened under an inverted 
microscope for positive cells, which were scraped into a small drop of wa- 
ter and picked with a hand-held pipette (Drummond, 509, Scientific Com- 
pany, Broomall, PA). Individual picked cells were treated with 200 ILl pro- 
teinase K (100 v.g/ml) in 0.6% SDS and 10 mM EDTA for 30 min at 37°(2, 
and a Hirt extraction was performed. Plasmid DNA was precipitated and 
transformed into E. coli strain Top 10F' by electroporation. Plasmids from 
pools of 10 colonies were recovered on spinbind columns (QIAprep Spin 
Plasmid Kit, Qiagen, Chatsworth, CA) and retransfected into COS.7 cells. 
A  mAb c264-reactive eDNA pool was identified, and after another round 
of electruporation and retransfection a  single plasmid clone, pc264, was 
isolated. Sequenase (Version 1.0; USB, Cleveland, OH) was used for se- 
quencing pc264 on both strands. The cDNA sequence has been submitted 
to the EMBL database with accession numbers Y08854 (soluble form), 
YO8855 (long cytoplasmic form), and YO8856 (short cytoplasmic form). 
A search in the EMBL data base showed that this sequence corresponded 
to a  recently isolated eDNA coding for gicerin. However, our sequence 
differed from the gicerin sequence at the 5' and 3' extremities (57, 58). At 
position 310 of gicerin sequence, one C is replaced by one T  changing a 
proline in leucine. At position 326, one C was missing whereas at position 
466 another C  was inserted changing the reading frame between amino 
acid residues 43 and 77. To confirm our eDNA sequence, we sequenced 
RT-PCR products from thymocytes and we determined the exact NH2- 
terminal amino acid sequence of the c264 protein. By microsequencing, 
the 28 NH2-terminal residues were  determined to  be  RLEVYMPAV- 
LEVEIGSTARLECSFSIPG. At position 1644 and 1754 of the gicerin se- 
quence, one G and one T are replaced by one A  and one C, respectively. 
The CITI 2 (Paris, France), UWGCG (Genetics Computer Group, Madi- 
son, WI), and Prosite pattern search (EMBL, Heidelberg) software pack- 
ages were used for the analysis of the sequence data. Assignment of the 
HEMCAM immunoglobulin domains was performed using the rules as 
described (1). 
Semiquantitative PCR 
From day 9 onwards embryonic tissues were carefully microdissected and 
total RNA was prepared.  For cDNA synthesis, standard protocols and 
universal primers were used (51).  Semiquantitative PCR was done as 
described by Keller et al. (24, 51) and Ruiz et al. (24, 51). The amount of 
eDNA synthesized was calibrated from the relative expression level of 
[3 actin as a  standard. The two actin oligonucleotide primers, 4611 and 
4612, generated a band of 646 nucleotides (13). A series of 10-fold dilution 
was used to standardize the eDNA. The oligonucleotides coveting the 
coding sequence of HEMCAM were: 11169 (HEMCAM, from nucleotide 
195)  ATGGCTGGGGGGCGACGGGCG;  11260  (HEMCAM,  from 
nucleotide 609) GGAGAGCCGCACCGAGC~CTACACC; 11261 (HEM- 
CAM, from nucleotide 634, antisense) GGTGTAGAGCTCGGTGCG- 
GCTCTCC;  11188  (HEMCAM,  from  nucleotide  1097)  GGAGAG- 
AGCTGGGGGACAGCTGG; 11106 (HEMCAM, from nucleotide 1363, 
antisense)  GCITGACGGGGCTGTGGGC;  11898  (HEMCAM,  from 
nucleotide 1597) TGCAAGGCCATCGCCITC; 11902 (HEMCAM, from 
nucleotide  2100,  antisense)  AAGCACTrAGGAGATCGC;  GIC1 
(HEMCAM,  from  nucleotide  2448,  antisense)  AAAAGAAACGTC- 
CCATCAGC; 4611 (5' of actin, from nucleotide 3598) TACCACAATG- 
TACCCTGGC; and 4612 (3' of actin, from nucleotide 4246, antisense) 
CTCGTCTTGTITI'ATGCGC. PCR reaction mixtures in 30 p.l with 1 U 
Taq polymerase (Perkin-Elmer Cetus, Norwalk, CT) were denatured by 
heating to 96°C for 5 min, and then subjected to 30 rounds of amplification 
using a Biometra Protocol thermocycler under the following conditions: 
96°C for 15 s, 50°C for 40 s, and 72°C for 1 rain for cDNA amplification. 
Final extension was done at 72°C for 10 min. Amplified DNA fragments 
were gel purified and cloned into pCR II (Invitrogen). Sequences were 
determined from denatured double-stranded recombinant plasmid DNA 
using Sequenase (USB) in the chain termination reaction. 
Generation of Soluble Recombinant HEMCAM 
The vector pCDA3 containing the cloned HEMCAM cDNA was used as 
a PCR template for the amplification of the sequence encoding the extra- 
cellular domains of HEMCAM. The PCR primers were: 5'-ATFAGAG- 
CrCACCATGGCTGGGGGGCGACGGGC-3' (5' primer) and 5'-TAT- 
ACTTACCTCCTTTGCTCTCCGATGGCTITFG-3'  (3'  primer).  The 
amplified product was purified and inserted into the vector pHT4 contain- 
ing the mouse IgK constant region as a fusion partner, and the junctional 
regions were analyzed by nucleotide sequence analysis. The vector was 
cloned into competent E. coil K803 cells then transfected into J558L my- 
eloma cells by protoplast fusion. Supernatants of the transfected myco- 
phenolic acid and xanthine resistant cell clones were screened by ELISA 
with goat anti-mouse cK reagents (Southern  Biotechnology). Superna- 
tants were  purified  by affinity chromatography with  a  monoclonal rat 
anti-mouse CK antibody (clone 187.1). The purified molecules were equil- 
ibrated with PBS and used for NH2-terminal amino acid sequencing and 
for immunizations of mice in order to produce mAb. For sequencing, the 
protein was transferred to Immobilon-P membrane (Millipore, Bedford, 
MA) and loaded into the cartridge of 475A protein sequencer (Applied 
Biosystems, Foster City, CA). 
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Soluble recombinant HEMCAM protein was injected into a rabbit at 100 Ixg 
in complete Fretmd's adjuvant followed by three injections of 100 I~g protein 
each in incomplete adjuvant. The specific serum, but not the pre-immune 
serum, reacted with chicken thymocytes and HEMCAM-transfected L 
cells at a dilution of 1:3,000,  and it cross-reacted with mouse pro-T lym- 
phocytes at 1:1,000. The polyclonai antibodies were purified on protein A 
columns, and anti-mouse ~ IgG was removed by absorbing the purified 
antibodies on a z containing affinity column. 
Transfection of L Cells 
The liposome-mediated transfection method was used to introduce pc264 
DNA into mouse L cells for stable expression of HEMCAM. A  day be- 
fore transfection, L cells (3 x  105 in 2 mi DMEM, 10% FCS) were plated 
on a  six-well plate (Costar, Cambridge, MA). Plasmid DNA (5 Ixg) was 
mixed with 20 }xl lipofectin (Lipofectamine, GIBCO BRL, Gaithersburg, 
MD) in a total volume of 100 ~1 Hz0 and left at room temperature for 30 
rain. Then, 800 }xl Opti-MEM medium (GIBCO BRL) was added to the 
DNA-liposome mixture,  and  after  rinsing the  L  cells  once  with  pre- 
warmed Opti-MEM medium, the mixture was overlayed on them and in- 
cubated at 37°C 5% CO2 for 5 h. After incubation I ml DMEM, 20% FCS 
was added to the well. At 24 h after transfection, the medium was replaced 
with fresh DMEM, 10% FCS. At 72 h  after transfection, the cells were 
trypsinized and plated at a 1:20 dilution into 96-well plates in DMEM, 10% 
FCS, and 1 mg/ml G418 (Geneticin, GIBCO BRL). Growing G418-resis- 
tant clones were tested for HEMCAM surface expression by flow cytometry. 
Progenitor Cell Assays 
Plasma clot assays for colony forming units were performed as described 
previously (9). Briefly, sorted cells were seeded in 1.2 ml of "Media Mix" 
(33)  composed  of  DMEM  (GIBCO  BRL),  10%  FCS  (Sigma),  2.5% 
chicken serum (Sigma), 0.15% NaHCO3, 56 ixg/ml conalbumin (Sigma), 
80 mM 2-mercaptoethanol, 0.9 i~g/ml insulin, and penicillin-streptomycin 
(GIBCO BRL). 120 pl of citrated bovine plasma (GIBCO BRL) and 10 
pJ thrombin (100 i.u./ml, Sigma) were added rapidly, and two 600-}xl all- 
quots from this mixture were  seeded  in  a  24-well  tissue culture  plate 
(Nunc). Cultures were incubated for 3 d at 37°C, harvested, and air dried 
onto microscope slides according to the methods described previously for 
collagen cultures (27).  Slides were stained for hemoglobin using diami- 
nobenzidine (32),  and counterstained with May-Grtinwald-Giemsa; col- 
ony types were assessed by morphology. In some experiments, cultures 
were supplemented with anemic serum (46) as a source of erythropoietin, 
chicken myelomonocytic growth factor (cMGF) (29), or stem cell factor 
(SCF) (55). Liquid culture experiments were performed as above, but bo- 
vine plasma and thrombin were omitted. The frequence of eosinophils 
and erythroid cells in liquid culture experiments were determined by sen- 
sitive, in situ stains for eosinophil-peroxidase (15, 23) and hemoglobins (36). 
Cell Aggregation and Spreading 
Adherent HEMCAM-transfected L ceils were rapidly trypsinized and re- 
moved from culture flasks by moderately vigorous pipetting with PBS. 
Cells were aggregated at 2 ×  106 cells/ml in DMEM (GIBCO BRL) con- 
taining 10% FCS at 37°C in popypropylene tubes (Falcon, Becton Dickin- 
son, Basel, Switzerland).  Particles were  enumerated at intervals in all- 
quots  taken  after  gently  turning  the  tube  in  order  to  resuspand  the 
sedimented aggregates. Aliquots were taken by pipettes with widened tips 
in order  to  avoid shear forces during aggregate collection.  Aggregates 
were counted in a Malassez chamber. Untransfected L cells were labeled 
by the fluorescent dye BCECF/AM (Calbiochem, San Diego, CA) by add- 
ing 2 I~1 stock solution (1 mg/ml in DMSO) to 1 ml cell suspension in full 
medium and incubated at 37°C for 20 min. After one wash the cells were 
ready to use for aggregation. 
Purified recombinant HEMCAM, PECAM-1, and VCAM-1 were di- 
rectly coated onto microtiter wells (Costar Corp., Cambridge, MA) at 10 
txg/ml in 50 ml D-PBS for 2 h at room temperature (43). The wells were 
blocked with 20% BSA for 1 h  at room temperature and washed with 
D-PBS. FTF1 mouse pro-T cells (a generous gift of R. Palacios, Houston, 
TX) were loaded in full medium (42) to the coated wells. The plates were 
then put under a microscope (Zeiss) equipped with a heated humid cham- 
ber at 37°C and a video-recording system (Panasonic). 
Results 
The Antigen Recognized by mAb c264 Is Expressed on 
Hemopoietic and Vascular Endothelial Cells 
To follow migration and differentiation of chicken T cell 
precursors, mAb were raised against surface molecules of 
embryonic  thymocytes  (E15).  At  this  stage  of develop- 
ment  many  pro-T  lymphocytes  have  already  migrated 
from the bone marrow,  the site of emergence, to the em- 
bryonic thymus (6, 11).  One of the antibodies, c264,  was 
selected because it detected an antigen on embryonic bone 
marrow cells, spleen cells, and thymocytes (Fig. 1). In em- 
bryonic bone marrow and spleen, many cell types, includ- 
ing erythrocyte precursors,  expressed the antigen recog- 
nized by mAb c264 (not shown). In the adult thymus, the 
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Figure  1.  Distribution of c264 + cells in embryonic tissues. E13.5 
H.B19 bone marrow, spleen, and thymus ceils were stained with 
mAb c264 followed by an FITC-conjugated second antibody spe- 
cific for the mouse Ig isotype. The thick curves show staining with 
c264 antibody, the faint curves with a control antibody. 
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in Liquid Medium 
SCF 
Growth  SCF  SCF  cMGF 
"xx....~actors  cMGF  EPO  EPO 
Cell type  ~  Cell No X los 
HEMCAM+/c-kit +  10.5  8.7  6.5 
HEMCAM+/c-kit-  0.6  0.6  0.5 
HEMCAM-/c-kit-  0.1  0.1  0.1 
Embryonic E13.5  bone marrow cells were sorted for the expression level of HEM- 
CAM and c-kit. The sorted ceils were then cultured in liquid suspension at 10  s ceils 
per well in the  presence of hemopoietic growth factors; stem cell factor (SCF), 
chicken erythropoietin (EPO),  and chicken myelomonoeytie growth factor (cMGF). 
The number of cells after culturing for 5 d is indicated. 
Figure 2.  Immunohistochemistry  of c264 antigen  expression  in 
the thymus. Frozen tissue sections of the thymus from a hatched 
chick were stained  by mAb c238 specific for c264 antigen  and 
best suitable for histochemistry. The bound antibody was visual- 
ized by a staining kit containing a peroxidase-conjugated reagent. 
The immune  reaction appears  in brown, the counterstaining  of 
the tissue in blue. (a) The cortical region of the thymus contained 
c264-antigen-positive thymocytes. (b) Thymocytes  in the cortico- 
medullary junction were negative for c264 antigen expression but 
the vascular endothelium of thymic blood vessels were stained. 
(ic) inner cortex; (oc) outer cortex; (m) medulla. Bar represents 
50 ~m. 
(double negative) as well as on all double positive thymo- 
eytes. The c264 antigen was also expressed albeit at lower 
levels, by CD4-,  CD8 ÷ cells but was absent from CD4  ÷, 
CD8- single positive cells (data not shown). The antigen was 
expressed at 100-fold lower levels, as determined by rela- 
tive fluorescence intensity, on cells of the B  lymphocyte 
lineage (data not shown). For immunohistochemistry, we 
used mAb  c238 because it recognized the  C264 antigen 
Table II. Colony Differentiation Assay in Semisolid Medium 
and it was most suitable for histochemistry. It reacted most 
strongly with thymocytes in the outer cortex of the thymus 
of newly hatched chicks (Fig. 2 a). Staining of cells in the 
inner cortex was clearly weaker, and most medullary thy- 
mocytes appeared  to be c264-negative. The antigen was 
also expressed at high levels by vascular endothelial cells, 
as exemplified by thymic capillary endothelial cell staining 
(Fig. 2 b). Thus, mAb c264 seems to be specific for an anti- 
gen that is most prominently expressed on cells of the T 
lymphocyte lineage and on vascular endothelium. The ex- 
pression of the c264 antigen was not exclusively restricted 
to the thymus since it was also found in other tissues such 
as spleen, bursa of Fabricius, gut, muscle, and brain of 3-wk- 
old chicks (Fig. 3). In all these tissues the antigen is ex- 
pressed  by  vascular  endothelium,  although  it  was  also 
found in epithelial cells of the bursa (Fig 3, b and c) and in 
myocytes (Fig. 3  e). In the brain however, only vascular 
endothelium was stained by the antibody (Fig. 3 f). Anti- 
body c264 precipitates a molecule with an apparent molec- 
ular mass of 98 kD, under both reducing (Fig. 4) and non- 
reducing  conditions  (not  shown).  After  treatment  with 
N-glycanase, the core protein migrated at -,~84 kD; thus, 14 
kD are due to N-linked glycosylation. 
T Cell Differentiation  ofc264-positive Bone 
Marrow Cells 
As the c264 antigen is highly expressed by immature thy- 
mocytes as well as by embryonic bone marrow cells, we as- 
sayed the c264 positive bone marrow cells for hemopoietic 
precursors able to differentiate into T cells. To this end, we 
Type of colony 
Cell type  Growth 
5 ×  10  z  factors  Mac  Gran  Mac/Gran  Myl/Mac  Myl  Ery/Thro  BFU-E  Sla'omal 
HEMCAM+/c-kit  +  SCF/EPO  49  23  6  9  2  26  1 +  0 
SCF/cMGF  37  13  3  8  5  6  2  0 
HEMCAM +/c-kit  -  SCF/EPO  6*  1  1  0  1  2  1  0 
SCF/cMGF  5*  1  0  0  1  0  1  0 
HEMCAM-/c-kit-  SCF/EPO  1  *  0  0  0  0  0  1  1 
SCF/cMGF  1  *  0  0  0  0  0  0  0 
Embryonic E13.5 bone marrow cells were sorted for the expression level of HEMCAM and c-kit. These cells were placed into semisolid medium containing bovine plasma and 
the following growth factors; stem cell factor (SCF),  chicken erythropoietin (EPO),  and chicken myelomonocytic growth factor (cMGF).  Cultures were incubated for 3 d, har- 
vested, dried, stained by May-Grtinwald Giemsa solutions to visualize myeloid cells, and diaminobenzidine  to stain erythroid cells. Colonies were then counted and analyzed by 
microscopy. Colonies contained:  Macrophages (Mac), Granulocytes (Gran),  Macrophages and Granulocytes (Mac/Gran),  Immature Myeloid cells and Macrophages (Myl/Mac), 
Immature Myeloid cells (Myl), Erythroeytes and Thrombocytes (Ery/Thro),  Erythroid burst forming cells (BFU-E),  and Stromal cells (Stromal).  *small  mature colonies; +  imma- 
ture colonies. 
Vainio et al. HEMCAM  and Hemopoietic Progenitois  1659 Figure 3.  c264 antigen expression in various tissues. Frozen tissue sections of a 3-wk-old chick were stained by mAb c238 as described 
for Fig. 1. (a) Spleen, it showed prominent staining of blood vessels; capillaries (C), arterioles (A). The T-lymphoid tissue in periarteri- 
olar lymphoid tissue, PALS (Pa), and the B-lymphoid tissue in perielipsoidal  lymphoid tissue, PELS (Pe), are not stained. The stroma in 
the red pulp (R), mainly sinuses, are strongly stained. (b) Bursa of Fabricius, note the strong staining in the cortico-medullary  junction. 
(c) Bursa of Fabricius at 4× higher magnification. All the cortico-medullary  capillaries  and the thin epithelial  monolayer are stained. (d) 
Intestinal villus, the blood vessels in the lamina propria are stained. (e) Skeletal muscle, the arterioles (A), and the venules (V) are 
strongly stained. All plasma membranes of myocytes are stained (tO. Brain, all the blood vessels are stained, neural tissue was generally 
negative. Bars represent 50 ~m. 
sorted c264 + and c264- E13.5 bone marrow cells (H.B19ov ÷ 
animals)  and injected them  intrathymically into  14-d-old 
H.B19ov- congenic animals. Thymus reconstitution by the 
ov  ÷  donor bone  marrow cells was  measured  by flow cy- 
tometry with the anti-ov mAb 11A9 at 2 wk after injection. 
In a  representative experiment, 500 sorted c264 + cells led 
to 5% thymocyte chimerism while up to 10,000 c264- cells 
induced no chimerism (Fig. 5). To obtain a  similar recon- 
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Figure 4.  Biochemical  analy- 
sis of c264 antigen.  The thy- 
mocytes from a three-wk-old 
chicken  of the  strain H.B19 
were 125I-labeled, and the ly- 
sate  precipitated  with  mAb 
c236 obtained by immuniza- 
tion  with  soluble  recombi- 
nant HEMCAM protein. Im- 
munoprecipitates  were 
analyzed by SDS-PAGE on a 
7.5% gel under reducing con- 
ditions  (a). In b, the precipi- 
tated protein was digested by 
N-glycanase  before  analysis 
by SDS-PAGE. The molecu- 
lar weight standards are indi- 
cated on the left. 
stitution level with total bone marrow, about 15,000 cells 
were needed (not shown). 
In the  mouse and human systems, it has been demon- 
strated that early hemopoietic progenitors can be greatly 
enriched on the basis of expression of c-kit, a tyrosine ki- 
nase-type receptor for hemopoietic stem cell factor (35). 
Recently,  we  generated  an  anti-chicken  c-kit mAb  (see 
Materials and Methods). We sorted c264-positive cells on 
the  basis of the  expression of c-kit.  Strikingly, we found 
that virtually all c-kit positive cells in the bone marrow ex- 
pressed the c264 antigen (Fig. 6 a). Sorting of c264 +, c-kit  + 
double  positive  cells  resulted  in  a  population  that  was 
highly  enriched  for early progenitor cells  and  extremely 
potent in the T  cell differentiation assay. In limiting dilu- 
tion experiments, injection of as few as three c264 +, c-kit  + 
bone marrow cells resulted in clear T  cell chimerism in a 
substantial fraction of recipients. The estimated frequency 
of T  cell precursors  in  the  c264 +,  c-kit  + double positive 
population was ~0.17 (Fig. 6 b). 
To test whether the c264 antigen +, c-kit  + bone marrow 
cell population also contained progenitors for the myeloid 
and/or the erythroid lineages, we assayed growth and dif- 
ferentiation in vitro in the presence of chicken stem cell 
factor (SCF), myelocytic growth factor (cMGF), and eryth- 
Log fluorescence  ov 
Figure  5.  Thymus  reconstitution  by  intrathymic  injection  of 
sorted c264  + embryonic bone marow cell populations.  (a) Dem- 
onstration of ov chimerism in the thymus two weeks after in- 
trathymic injection  of 500 H.B19ov  ÷ c264  + bone marrow cells 
into irradiated 14-d-old H.B19ov- recipients.  Ov-positive cells in 
injected  thymus  lobes  were  detected  by  immunofluorescence 
staining  with mAb llA9.  (b) Demonstration of the absence of 
thymus chimerism when 10,000 c264- cells were injected. 
ropoietin (EPO).  All the combinations stimulated prolif- 
eration of the sorted c264 +, c-kit  + cells but not single posi- 
tives or double negatives (Table I). Culturing of 1  x  105 
double positive cells for 5 d resulted in 6.5-10.5  ×  105 dif- 
ferentiated cells of all myeloid or erythroid lineages (Ta- 
ble I and not shown). When the double positive cells were 
cultured under semi-solid growth conditions,  there was a 
high frequency of mixed colonies (Table If). These results 
suggest  that  c264  antigen  and  c-kit  are  present  on  he- 
mopoietic progenitors of all lineages. 
The c264 Antigen Is Homologous to the Human 
Melanoma Progression  Marker MUC  I 8 
Since embryonic thymocytes showed the  highest  expres- 
sion level of the c264 antigen, a cDNA library was made 
from E13.5 thymus polyA  + mRNA. The library was con- 
structed into the pCDA3 vector, which allowed expression 
of cDNA in  eukaryotic cells (COS 7).  Using expression 
screening with mAb c264, we isolated one clone from tran- 
siently transfected COS cells. This clone has an open read- 
ing  frame of 1,878  bp that  corresponded  to  a  recently 
isolated cDNA encoding gicerin,  a  molecule involved in 
neurite outgrowth. Among nucleotide differences, at posi- 
tion  326  of  the  gicerin  sequence,  one  C  was  missing 
whereas at position 466 another C  was inserted changing 
the reading frame between amino acid residues 43 and 77 
(Fig. 7 and not shown) (56, 57). We confirmed the cDNA 
sequence by NH2 terminus amino acid sequencing of the 
recombinant soluble protein produced in J558L myeloma 
cells (28 amino acid residues). The leader peptide was un- 
usually long (35 amino acids) and it contained six cysteine 
residues. In the NH2 terminus c264 sequence a new puta- 
tive N-linked glycosylation site was found. 
The predicted amino acid sequence of the c264 protein 
identified this molecule as a  member of the type I  trans- 
membrane protein  of the  IgSF, with five extracelluar  Ig 
domains, two of them of the V-like and three of the C2- 
like,  in  the  order  V-V-C2-C2-C2.  The  extracellular  do- 
mains  showed  nine  putative  N-glycosylation  and  seven 
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Figure 6.  Thymus  reconstitution  after  intrathymic injection  of 
c264 + c-kit  + bone marrow cells. (a) Bone marrow cells derived 
from E13.5  H.B19  animals  stained  for c-kit and  c264  antigen. 
Populations  1,  2,  and  3  define  c264 ÷  c-kit  +,  c264 ÷ c-kit-  and 
c264- c-kit- cells, respectively. (b) Frequency of T cell precursors 
in c264 + c-kit  + E13.5 bone marrow population. Titrated numbers 
of c264 + c-kit  + ov  ÷ cells were injected intrathymically into ov- 
recipients and the thymuses were assayed two weeks later for ov  + 
cells by flow cytometry. 
myristylation  sites.  Among  the  IgSF  molecules  in  the 
EMBL  data  base  MUC18  showed  high  homology  (39%) 
with the c264 protein (Fig. 7). MUC18 is a human member 
of the  V-V-C2-C2-C2  family  and  is  a  marker for  human 
melanoma  tumor progression  (28).  Significant  but  lower 
homology was also found  with other five  Ig-domain  pro- 
teins  from various  species:  B-CAM  (27%,  human),  AL- 
CAM  (25%,  human),  BEN  (25%,  chicken), and neurolin 
(28%,  fish).  There  was  much  higher  homology  between 
chicken  c264  and  human  MUC18  in  the  transmembrane 
(66%)  and cytoplasmic regions (69%).  Exon 13 of MUC18, 
which encodes 34 amino acid residues located between the 
last  Ig  domain  and  the  transmembrane  region  is  not 
present in c264 (Fig. 7). Because  of the expression by he- 
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Figure 7.  Alignment of amino acid sequences of chicken HEM- 
CAM  and  human  MUC18  precursors.  Gaps  have  been  intro- 
duced to maximize alignment scores. The thin solid line indicates 
the leader peptides, the thick solid line the putative transmem- 
brane domain. Numbered arrows above the sequences show the 
conserved cystein residues of each Ig domain. Stars show poten- 
tial N-linked glycosytation sites. Identical or similar amino acid 
residues are indicated by a double or a single bar, respectively. 
The long gap in HEMCAM  sequence starting from residue 531 
corresponds to amino acids in human MUC18 sequence encoded 
by exon 13. 
mopoietic  cells,  the  structural  similarity  and  the  high  se- 
quence  homology  to  MUC18,  we  call  the  c264  protein 
HEMCAM  (Hemopoietic, MUC18 related, Cell Adhesion 
Molecule).  It  was  interesting  to  note  that  HEMCAM 
showed higher sequence homology to MUC18 in the NH2- 
terminal region than gicerin to MUC18. 
As  two different  cytoplasmic sequences  have  been  ob- 
served  in  gicerin  and  HEMCAM,  we  searched  for  the 
presence of cDNA  splicing variants (56) with reverse tran- 
scriptase PCR (RT-PCR)  on several tissues. Three differ- 
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Development 
Days of 
development  9  10  11  12  13  14  15  17  35 
Bone  nd  ++  ++  ++  ++  ++  ++  ±  ± 
marrow 
Thymus  +  ++  ++  ++++  ++++  ++  +++  ++++  ++ 
Spleen  nd  + +  +  +  -Z-_  _+  _+  ---  + 
Bursa  nd  +  ++  +++  +  +  nd  ++  +++ 
Intestine  nd  +  +  +  +  +  + +  + +  - 
Liver  nd  ++  ++  ++  ++  ++  ++  +++  ++ 
Muscle  nd  ++  nd  nd  +++  nd  nd  ++++  +++ 
Brain  nd  + +  nd  nd  nd  nd  nd  + +  + + 
Blood cells  nd  ÷  +  nd  + +  nd  nd  + +  + 
Kidney  nd  nd  nd  nd  + +  nd  nd  nd  + 
The pattern has been established with a semiqualitative  PCR-technique  using oligonu- 
cleotide  primers 11188 and 1  t 106 which allow amplification  of an invariant  part of 
HEMCAM transcripts  (see Materials and Methods). The PCR products have been an- 
alyzed by agarose gels and the intensity of the appearing bands is indicated by a grad- 
ing from (-) no band to a (+ + + +) band at saturation levels. 
Figure 9.  Expression of HEMCAM mRNA encoding  the cyto- 
plasmic variants during embryogenesis.  RT-PCR analysis of em- 
bryonic bone marrow and thymus from day 9 (E9) of develop- 
ment  onwards  was  done  with  a  combination  of  two  primers 
depicting  mRNA coding for the long or short cytoplasmic forms 
(11898-11902). After 30 cycles of amplification,  PCR products 
were separated on a 1.2% agarose gel. The short form appears as 
the lower band at 384 bp and the long form at 503 bp. (M) DNA 
molecular weight markers 1 kb ladder.  (C) Control sample con- 
taining the primers but no templates, nd, not determined. 
ent mRNA forms encoding putative RNA splicing variants 
were identified in the 3' end (Fig. 8). The first transcript 
corresponded to the HEMCAM sequence with a long cy- 
toplasmic tail. Another encoded a short cytoplasmic vari- 
ant that was identical with the COOH-terminal end of the 
gicerin sequence. The third transcript would lead to a solu- 
ble protein truncated just before the transmembrane region. 
During development, HEMCAM is expressed as early 
as El0 in several organs, including bone marrow, thymus, 
spleen, bursa, intestine, liver, and brain, as determined by 
RT-PCR with primers detecting all variants (Fig. 9 and Ta- 
ble III). The mRNA splice variants encoding the short and 
the long cytoplasmic tails were present in equal levels at 
all stages of development in the bone marrow (Fig. 9). In 
the developing thymus however the short variant predom- 
inated during early embryonic stages, while the long form 
was present in later stages and predominated in thymus of 
hatched  chicks.  Two PKC phosphorylation  sites at posi- 
tions 573 (RSGK) and 594 (KSDK) are conserved in hu- 
man MUC18. Although there is a conserved tyrosine resi- 
due at the cytoplasmic tail, neither HEMCAM nor MUC18 
has a potential tyrosine phosphorylation site, as defined by 
the Prosite pattern data base. 
481 
Long  S  I  NGTTHE  YMENQHMAS  NLTVRVS  HDLLE~AGAMCRVSNALGVS  EKH  I  (~LLDOKP  S  E  S  KG~  540 
Sh~rt  ............................................................  540 
Soluble  .....  VRAGRVLWAALG~GAVRGC  504 
541  +  *  + 
Lon  9  T  Iv~  T  TVC  T  L%~/AVL~  ~  T  T  ~  LH  K]EGK  I  S  CGRSGKQD  I  TKP  EARXD  ~TVVEVK  SDKL  $EE  80D 
s~orr.  ......................................  ARNT~Z  584 
soluble  504 
601  *  + 
Long  AGLI~GANGEKRS  PAD,S  EKY  I  DLKN  826 
Short  594 
Soluble  504 
Figure 8.  Predicted  amino  acid sequences  of three mRNA  splic- 
ing variants of HEMCAM. The sequences  shown start from resi- 
dues 481. "Long" and '"short" indicate  the long and short forms 
of the cytoplasmic tails of HEMCAM; soluble corresponds to the 
putative soluble form of HEMCAM ending at residue  504. +, *, 
and. indicate possible phosphorylation sites for protein kinase C, 
casein kinase II, and calmodulin kinase II, respectively. 
HEMCAM Confers Cell Spreading and Cell Adhesion 
by Homophilic Interaction 
HEMCAM cDNA coding for the short and the long cyto- 
plasmic variants were transfected into mouse L cells. Both 
forms of HEMCAM led to cell-cell adhesion in a suspen- 
sion assay (Fig. 10 A). In transfected cell lines, the average 
size of aggregates was four cells, while in control, untrans- 
fected cell lines, the average was 1.2 cells. The largest ag- 
gregates were 30 cells in the transfected lines, while aggre- 
gates larger than four or five cells were never seen in the 
controls. Soluble recombinant HEMCAM molecules and 
anti-HEMCAM antibodies blocked cell adhesion confirm- 
ing that the adhesion was HEMCAM specific (Fig 10 B). 
And finally, the aggregation of transfected L cells was me- 
diated by homophilic interaction of HEMCAM molecules, 
since  untransfected  cells  were  not  found  in  aggregates 
formed by HEMCAM expressing cells (Fig. 10 C). 
A  mouse pro-T lymphocyte cell line  (FTF1)  bound  to 
recombinant chicken HEMCAM, mouse PECAM-1,  and 
mouse VCAM-1, all molecules found on vascular endothe- 
lia  (21).  When  HEMCAM  of adherent  pro-T cells was 
cross-linked by a purified polyclonal antibody that recog- 
nizes chicken  and  mouse HEMCAM  (see Materials  and 
Methods), the cells exhibited significant spreading on PE- 
CAM-l-, VCAM-I-, and HEMCAM-coated surfaces but 
not on control BSA (bovine serum albumin) (Fig. 10 D). 
Thus, HEMCAM seems to be able  to mediate adhesion 
and induce cell spreading, probably by activating cytoskel- 
etal elements after signal transduction. 
Discussion 
We have characterized and cloned HEMCAM, a molecule 
expressed by hemopoietic progenitor cells in  embryonic 
bone marrow, thymocytes, and capillary endothelial cells. 
HEMCAM-expressing cells sorted from bone marrow were 
enriched  in  progenitors able  to differentiate  into  T  cells 
when transferred into the appropriate thymic microenvi- 
ronment. An extremely high frequency of T  cell precur- 
sors  of 0.17  was  found  among embryonic bone  marrow 
cells expressing both HEMCAM and the receptor tyrosine 
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were observed; two have transmembrane domains with cy- 
toplasmic tails of 63 or 21 amino acids, and one lacks both 
transmembrane and cytoplasmic regions. HEMCAM which 
is almost identical to gicerin, a molecule involved in neural 
outgrowth (57), is also homologous to human MUC18, a 
molecule expressed  by highly metastatic  melanoma cells 
(28). The function of HEMCAM seems to be mediation of 
cell-cell adhesion as well as cell spreading of pro-T lym- 
phocytes.  We  concluded  that  HEMCAM  could  be  in- 
volved in the colonization of the thymus by hemopoietic 
progenitor cells. 
Although progenitor cells represent an extremely small 
population  in the  mouse,  <0.05%  of leukocytes in adult 
bone marrow, a much higher frequency was found in fetal tis- 
sues (e.g., 8% of all leukocytes in fetal blood [20, 34, 49]). 
Embryonic bone marrow cells, which are easily obtainable 
in  the  chicken,  are  also  highly  enriched  in  hemopoietic 
progenitors (11). Here we have characterized the pheno- 
type of these progenitor cells, and, as expected from mouse 
and human data, hemopoietic progenitors expressed c-kit. 
More importantly, we showed that the c-kit  + progenitors 
coexpressed the adhesion molecule HEMCAM. 
Three V-V-C2-C2-C2 IgSF molecules are known in hu- 
man beings: BCAM, ALCAM, and MUC18. Two forms of 
BCAM are generated by alternative splicing; BCAM and 
the  Lutheran  blood  group  antigen.  (5,  38).  BEN,  DM- 
GRASP,  and  SC1  are  homologues  of ALCAM  in  the 
chicken, or KG-CAM in the rat  and neurolin  in the  fish 
(Fig. 11). HEMCAM differs from gicerin by a stretch of 35 
amino acids at the NH2 terminus. However, this difference 
is due to an insertion and a  deletion of one nucleotide at 
each side of the borders of this stretch, leading to a frame 
shift. The few nucleotide substitutions  observed between 
the two sequences make it likely that HEMCAM and gic- 
erin are the same molecular entity. The high GC percent- 
age in the NH2 terminus region may account for the possi- 
ble errors encountered in the gicerin sequence (57). Two 
different clues suggest that our nucleotide sequence is the 
correct one: first, the determined amino acid sequence of 
our recombinant HEMCAM  protein fits with the eDNA 
sequence and second, the amino acids 43 to 77 of HEM- 
CAM and not those of gicerin are homologous to MUC18, 
a  human metastatic  melanoma marker  (28),  at the same 
level as the rest of the extracellular part of the HEMCAM 
or gicerin proteins. Overall, the HEMCAM amino acid se- 
quence is homologous to 39% with MUC18. Although the 
homology was relatively low in the extracellular part, 32- 
40%  for each Ig domain, the transmembrane  and the cy- 
toplasmic  domains  were  highly  homologous,  66%  and 
69%, respectively. This suggests that intracellular  ligands 
of HEMCAM, or proteins with which HEMCAM  forms 
complexes in the membrane should be well conserved dur- 
ing  evolution,  while  extracellular  ligands  might have  di- 
verged. Two of the potential PKC phosphorylation sites of 
the HEMCAM long form, at positions 573 and 594, were 
conserved  in  human  MUC18  further  strengthening  the 
possible functional homology of these proteins. The main 
difference between MUC18 and HEMCAM is the absence 
in HEMCAM  of a  stretch of 34 amino acids located be- 
tween the last Ig domain and the transmembrane  domain 
of MUC18.  These  residues  are  encoded  by  exon  13  of 
A 
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Figure  10.  HEMCAM,  an 
adhesion  molecule  involved 
in cell spreading. (A) Aggre- 
gation  of  HEMCAM-trans- 
fected cell lines. Control and 
transfected  L  ceils  (HEM- 
CAM cytoplasmic short and 
long  variant)  were  cultured 
in suspension at 2 x  106 cells/ 
ml in full medium at 37°C. At 
indicated time points, the cell 
suspension  was  gently  agi- 
tated, and the number of par- 
tides  (cell  aggregates)  were 
counted in a small aliquot in 
a  hemocytometer.  Data  are 
expressed  as  the  average 
number  of cells  per  aggre- 
gate.  (B) L cells  transfected 
with the long variant form of 
HEMCAM were allowed to 
aggregate at 2 x  10  6 cells/ml 
for  100  min  at  37°C  in  the 
presence  of  control  mouse 
IgG  (co),  soluble  HEM- 
CAM  (sol),  or  polyclonal 
anti-HEMCAM  antibody 
(anti).  The  aggregation was 
blocked when the cells were 
incubated in the presence of 
50 ixg/ml of recombinant sol- 
uble  HEMCAM (sol)  or 50 
~g/ml of purified polyclonal 
rabbit  anti-HEMCAM  anti- 
body (anti).  (C)  HEMCAM mediates  L cell aggregation  by ho- 
mophilic interaction. L ceils, transfected with the long variant form 
of HEMCAM were allowed to aggregate at 2 ×  106 cells/ml for 
100 or 200 min, respectively (hatched bars).  In a simultaneous 
experiment transfected L cells  at 2  x  10  6 cells/ml  were mixed 
with nontransfected control L cells at 2 X 10  6 cells/ml which have 
been previously labeled with the fluorescent dye BCECF. The 
average number of cells per aggregate was assessed  by a micro- 
scope equipped by epifluorescence (solid bars). In 30 aggregates 
the number of fluorescent and unstained cells were counted and 
expressed as an index given on top of the bars, it is calculated as 
the number of labeled cells (control L cells) divided by the num- 
ber of unlabeled cells (transfected L ceils). Note that the aggre- 
The Journal of Cell Biology,  Volume 135, 1996  1664 gates in 1:1 cell mixtures were smaller and contained mostly transfected cells. (D) Soluble recombinant HEMCAM, PECAM-1, VCAM-1, 
or control BSA were coated onto culture dishes. FTF1 pro-T lymphocytes were allowed to adhere to the coated dishes for 20 min at 37°C, 
and the nonadhering cells were removed. The spreading of adherent cells was observed over 2 h by video-microscopy; photographs were 
taken at the end of this observation time (control).  Then, polyclonal anti-HEMCAM  antibody was added  at 50 i~g/ml to cross-link 
HEMCAM. Cell spreading occured after a further 15-20 min at 37°C, and photographs were taken at 20 min after (crosslinked). Bar, 10 ~m. 
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Figure 11.  Evolutionary tree of proteins belonging to the family 
of V-V-C2-C2-C2- IgSF. 
MUC18  (53).  In fact, these 34 amino acids correspond 
exactly  to  a  mucin  repeat  found  in  human  molecule 
SMUC-40 (16). Such structural differences have been pre- 
viously encountered in homologous molecules in different 
species. For example, in the mouse MAdCAM-1, a large 
mucin domain replaced an Ig domain present in human 
MAdCAM-1  (54). Thus, taken together, our data suggest 
that  HEMCAM  is  the  chicken  homologue  of  human 
MUC18. 
We identified three HEMCAM mRNA splice variants. 
Two of them encode transmembrane proteins that vary in 
their cytoplasmic tail. This may be of importance for the 
protein function since the cytoplasmic domain of the long 
form has three protein kinase C (PKC) and two casein ki- 
nase II (CKII) phosphorylation sites, the short form has 
only one of these PKC sites in common along with a calmod- 
ulin kinase 2 phosphorylation site. The capacity for differ- 
ential phosphorylation of the short and long cytoplasmic 
forms of HEMCAM might have consequences for signal 
transduction into the cell and/or inside out signaling lead- 
ing to different ligand specificities. This is further empha- 
sized by the fact that the two forms have temporally differ- 
ent expression patterns  in the thymus.  It remains to be 
determined whether or not differentiating thymocytes and 
thymic vascular  endothelial  cells  express both forms of 
HEMCAM.  The  nucleotide  sequence  missing  from the 
short cytoplasmic HEMCAM  transcript  corresponds ex- 
actly to exon 15 of MUC18. It suggests that MUC18 and 
HEMCAM genes have the same structure. In this context 
the generation of the two alternative transcripts is easy to 
understand. The transcript encoding the short cytoplasmic 
form would be generated by direct junction of the exons 
homologous to exons 14 and 16 of MUC18, while the tran- 
script encoding the soluble form would result in the ab- 
sence of splicing of the intron homologous to intron 11 of 
MUCI8 (53). 
As HEMCAM is expressed by hemopoietic progenitor 
cells and has mostly disappeared in differentiated T cells, 
we think this molecule might contribute to a specific mecha- 
nism  allowing  hemopoietic  progenitors  to  colonize  the 
thymus. As it is an adhesion molecule and it belongs to the 
V-V-C2-C2-C2  family,  HEMCAM  would  likely  be  in- 
volved in an adhesion process allowing hemopoietic pro- 
genitor cells to attach to the luminal plasma membrane of 
the vascular endothelial cells. As it is a variant of gicerin, 
HEMCAM  should  exhibit similar  adhesion specificities; 
e.g., homophilic interactions and heterophilic interaction 
with  NOF,  a  laminin-like  molecule  (18).  Interestingly, 
HEMCAM is expressed on vascular endothelium, which 
may  allow  progenitor/endothelial  cell  adhesion.  More- 
over, as is the case with many other adhesion molecules of 
the  IgSF  family  (14),  a  physiological  soluble  form  of 
HEMCAM  can  be  produced.  Soluble  HEMCAM  may 
play a role in the regulation of thymus homing, inhibiting 
progenitor/endothelial cell adhesion by competitive bind- 
ing to its ligand on the plasma membrane. It remains to be 
determined whether the two cytoplasmic domains are in- 
volved in inside out signaling leading to different ligand 
specificity. For example, it has recently been shown that 
alternatively spliced tails of PECAM-1 determine whether 
the molecule interacts in a homophilic or heterophilic man- 
ner (62). At present, we are testing such a regulation of 
ligand specificity with HEMCAM. The strength of HEM- 
CAM adhesion is weak in comparison to adhesion with se- 
lectins, integrins, and other IgSF proteins such as ICAMs, 
VCAM-1, and PECAM-1. The main role of HEMCAM, 
whether it is a proper adhesion molecule or whether it acts 
as a modulator of adhesion through association with other 
adhesion molecules or they are involved in outside-in sig- 
naling, remains to be tested. 
Like  HEMCAM,  two  molecules  involved  in  thymus 
homing of pro-T cells, et6 integrin and the adhesion mole- 
cule CD44 play a role in tumor metastasis. The et6131 inte- 
grins are mediators of metastatic melanoma cell adhesion 
to the vascular endothelium (50), and the expression of a 
variant of CD44 confers metastatic potential to rat carci- 
noma cells  (17).  Gicerin, the  homologue of HEMCAM 
has  been  described  in  tumorigenesis  (58).  Both  HEM- 
CAM and its human homologue MUC18 participate in or- 
ganogenesis during development. At the adult stage their 
expression is restricted to a few tissues, but it may be in- 
duced during tumor progression (28). Understanding the 
normal function of these molecules ought to contribute to 
the understanding of their malfunction in tumors. 
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